In a new Wolters Kluwer report, it was revealed that 80% of respondents cited “optimizing workflows” as a top organizational ...

Ernst & Young study shows 85% of participating organization leaders are seeing better patient outcomes, and nearly 75% report ...

The pharmacy benefit manager (PBM) industry is under pressure to shift to models that avoid conflicts of interest and ...

While heritable human genome editing is banned in the United States, across Europe and much of the world, the technology ...

Although 52% of healthcare leaders believe a fatal cyber-related patient incident will happen within the next five years, ...

Researchers at MD Anderson discussed the five possible approaches to treating graft-versus-host disease in a review article ...

The approval is based on results from the phase 3 ARANOTE trial, which showed Nubeqa, when combined with androgen deprivation ...

The results feed into an effort to identify to monoclonal antibody combinations that would prevent and possibly treat HIV ...

Medicare Advantage plans have drawn the ire of lawmakers for aggressive coding. Investigations are underway. Some hope ...

Satellos Bioscience Chief Scientific Officer discusses early-stage trials of the company's Duchenne muscular dystrophy drug, ...

The Teal Wand was recently approved by the FDA as the first self-collection device to screen for cervical cancer, a major step forward for accessible women’s health, according to Rahma S. Mkuu, Ph.D., ...

Jeffrey Casberg, M.S., of IPD Analytics and Luke Greenwalt, MBA, of IQVIA, both members of the Managed Healthcare Executive (MHE) editorial advisory board, will provide a midyear assessment of the ...